Abstract
BACKGROUND
It is still unclear whether individuals with the same degree of obesity but different weight histories since young adulthood have different insulin concentration, prevalence of metabolic syndrome components and their clustering.
METHODS
A cross-sectional study was conducted on 3,399 (for weight difference analysis) and 1,879 (for weight fluctuation analysis) Japanese men aged 40-59 years. Weight difference was calculated by subtracting the recalled weight at about 25 years old from the current weight. The root mean square error around the slope of weight on age (weight - RMSE) was calculated by a simple linear regression model, in which the subject's actual weights at ages 20, 25, 30, 40 years and 5 years prior to the study, as well as current weight, were dependent variables against the subject's age as the independent variable. Each metabolic syndrome component was defined as follows: serum triglycerides ≥150 mg/dL; HDL-cholesterol <40 mg/dL; fasting glucose ≥110 mg/dL; and blood pressure ≥140/90 mm Hg.
RESULTS
Those who gained <10%, <20%, or 20% or more in weight had a significantly higher than unity odds ratio of having two or more metabolic syndrome components in relation to those whose weight remained stable: 1.28 (95% confidence interval: 0.95-1.73), 2.49 (1.91-3.24), and 5.30 (3.97-7.07), respectively. Weight-RMSE was significantly and positively associated with fasting insulin concentration independent of current weight, weight-slope or other lifestyle-related factors.
CONCLUSIONS
Metabolic syndrome components would likely tend to cluster more in individuals with large weight gain on a physiologic basis characterized by high fasting insulin concentration. Furthermore, weight fluctuation was suggested to increase the risk of fasting hyperinsulinemia.
Key words: Obesity, Weight Gain, Weight Loss, Insulin, Metabolic Syndrome X, Japan
Metabolic syndrome has been proven as a major determinant of ischemic cardiovascular diseases.1 Obesity is a central feature of the metabolic syndrome.2 However, evidence is not readily available whether individuals who have a similar degree of obesity but different weight histories since young adulthood would have a different prevalence of metabolic syndrome components and their clustering. Furthermore, insulin resistance or hyperinsulinemia has been considered to play a key role in the pathogenesis of clustering multiple cardiovascular risk factors.3 We, therefore, examined the association of longitudinal weight histories with fasting insulin concentration as well as metabolic syndrome component and their clustering in Japanese men. Because repeated weight loss and regain is a common phenomenon today due to intentional dieting or unintentional weight change caused by psychological stress,4,5 considerable attention has been paid to the possible deteriorating health effect of weight fluctuation.
METHODS
Subjects
To evaluate association between weight differences since about 25 years old and components of metabolic syndrome and their clustering, complete data from two worksites were used (n=3,548). In 1997, participants responded to a self-reported questionnaire including past weight at about 25 years old, medical history and lifestyle characteristics, and participated in an annual health check-up, in which they underwent a physical examination including height and weight measurement, and provided a collection of fasting blood samples.6 Those with a medical history of cancer (n=42) and diabetes mellitus (n=107) were excluded. Informed consent was obtained at both worksites. In another analysis to evaluate the association of long-term weight change slope and weight fluctuation with fasting insulin concentration, the weight history data were used from only one worksite on the actual weights at ages 20, 25, 30, 40 years old, and that of 5 years before (in 1992) from the respective health checkup records (n=2,020). Subjects with a medical history of cancer and diabetes mellitus were excluded from the present study (n=88). Finally, the current analysis was restricted to 1,879 men with complete available data on all of the actual weights at ages 20, 25, 30, and 5 years before, together with the serum insulin concentration of the provided blood sample, current weight, and other covariates. The study protocol was approved by the Ethics Review Committee of Nagoya University School of Medicine, Nagoya, Japan.
Definition of Weight Difference
Weight difference since about 25 years old was calculated for each participant by subtracting the self-reported weight at about 25 years old from the current weight obtained at the 1997 annual health check-up. Current weight and height in 1997 were measured in the morning fasting state to the nearest 0.1 kg and 0.1 cm, respectively, with subjects wearing light clothing and no shoe. Weight difference proportion was calculated by dividing the difference by the weight at about 25 years old. The difference proportion in percentage was categorized into five groups: 20% or more gain, 10-20% gain, 4-10% gain, within 4% (stable), and loss greater than 4%.
Body Mass Index and Weight Variability Indices
Body mass index (BMI) was calculated as weight in kilograms divided by the square of height in meters and used as the relative weight. Weight variability was divided into two distinct components, trend over time and fluctuation over time, using a simple linear regression model in which each of the subject's five or six actual weights (aged 20, 25, 30 , 40 years old, five years before, and current) was a dependent variable and the subject's ages at examination independent ones. The slope coefficient of this model was used to represent an individual's weight trend of direction and magnitude (weight-slope), while the root mean square error (RMSE) of this model, a standard deviation around this slope, was used to represent the weight fluctuation magnitude (weight-RMSE). The coefficient of variation (CV) of weight is commonly used to describe weight fluctuation, but a person with a slight and steady weight gain over a long period of time can have the same CV as a person with large weight gains and losses with no overall weight gain. As CV and slope are correlated, one cannot discriminate between a nonlinear slope effect and the instability of changes by CV itself. In contrast, RMSE can be a more sensitive measure of instability regardless of the overall trend.
Definition of Metabolic Syndrome Components and Their Clustering and Measurement of Insulin Concentration
Hypertension was defined as the state with either systolic blood pressure of 140 mmHg or higher or diastolic blood pressure of 90 mmHg or higher. Impaired fasting glucose (IFG) was defined as the state with the serum level of fasting blood glucose of 110 mg/dl or greater. High triglyceride (TG) level was defined as 150 mg/dL or greater. Low high-density lipoprotein cholesterol (HDLC) level was defined as less than 40 mg/dL. In this analysis, clustering of these components was defined as the state in which participants had two or more factors. Serum insulin concentration was measured by solid phase radio-immunoassay (RIABEAD II; Dainabot Co., Ltd., Chiba, Japan).
Definition of Lifestyle Variables
Smoking status was classified into four levels (never, past, current smoker of 1-24 cigarettes per day, and 25+). Drinking habit was first assessed by the number of drinking days per week (none, 1-3, 4-6, and daily). If present (not none), it was further categorized into three levels by weekly consumption (light, moderate, heavy), that is, daily alcohol consumption times days of drinking per week.7 A leisure-time physical activity was assessed by two questions about frequency (seldom, 1-3 times per month, 1-2 times per week, 3 times or more per week) and intensity (vigorous, moderate, light) of the physical activity in their free time. Those who engaged in vigorous activity, 1-2 or more times per week, or moderate activity, more than 3 times per week, were classified as 'regularly active.' Those who engaged in vigorous activity, 1-3 times per month, moderate activity, 1-2 times per week, or light activity, more than 3 times per week, were classified as 'somewhat active.' All others with nonmissing data on these questions were classified as 'not very active.' Vigorous activity was defined in the questionnaire as the level that leaves participants out of breath. Similarly, moderate activity was defined as the level that leaves participants breathing rather hard. Awareness of stress was assessed by the question: 'Do you have much stress in your life?' Participants were asked to select from among four responses: 'very much, ' 'much, ' 'ordinary, ' and 'little.'8
Statistical Analysis
Association between weight difference and component of metabolic syndrome together with their clustering was evaluated by multivariate logistic regression analyses taking stable group as a reference category and adjusting for the age, height, weight at 20 years old, smoking, drinking and physical activity. The associations were presented as the odds ratios (ORs) and the 95% confidence intervals (CIs). Mean fasting insulin levels were calculated for the quartiles of weight-slope and weight-RMSE, respectively. Study-specific quartile cut-points of weight-RMSE were 0-0.52, 0.53-0.97, 0.98-1.59, and 1.60-6.53 kg, and those of weight-slope were −0.54-0.12, 0.13-0.26 0.27-0.40, and 0.41-1.76 kg/year. We statistically adjusted the mean with age at baseline, BMI at age 20 and at baseline, and either weight-slope or weight-RMSE as covariates using a general linear model (Model 2). Further adjustment was also performed with the awareness of stress, smoking, drinking and physical activity status assessed by a baseline questionnaire (Model 3). These variables were entered into the model as covariates as equally spaced ordinal variable (awareness of stress) or dummy variables (others). Insulin concentration is presented as the geometric mean with 95% CI because of the skewness of the data. Differences among means were tested by analysis of covariance (ANCOVA) and post hoc multiple comparisons were performed by the Sidak method. Proportions were tested by chi square test. All reported p values were two-sided, and a p value less than 0.05 was considered statistically significant. Test of linear trend was performed considering quartile categories as equally spaced ordinal ones. All statistical analyses were performed with SPSS® for Windows.
RESULTS
Prevalence of hypertension, IFG, low HDLC, and high TG in individuals who gained 20% or more weight since the age of 25 were 42.9%, 18.5%, 17.2%, and 46.2%, in contrast to 21.5%, 10.6%, 7.8%, and 18.0% in those whose weight remained stable, respectively (Table 1). The differences in the proportions were significant in all the components (p<0.001, chi square test). ORs of having two or more metabolic syndrome components in those who gained <10%, <20%, or 20% or more in reference to those whose weight remained stable were 1.41 (95% CI: 1.08-1.85), 2.62 (2.06-3.33), and 5.81 (4.46-7.57), respectively (Table 2). Those who lost weight had a significant inverse association with clustering risk factors with OR 0.61 (0.41-0.90).
Table 1. Prevalence of metabolic syndrome components according to weight difference categories since about 25 years old.
| Weight difference categeries | n | Hypertension* | IFG* | Low HDLC* | High TG* |
| n (%) | n (%) | n (%) | n (%) | ||
| Loss (to −4.1%) | 278 | 60 (21.6) | 33 (11.9) | 19 (6.8) | 42 (15.1) |
| Stable (−4.0 to 3.9%) | 711 | 163 (22.9) | 75 (10.5) | 53 (7.5) | 119 (16.7) |
| Gain (4.0 to 9.9%) | 701 | 183 (26.1) | 59 (8.4) | 67 (9.6) | 167 (23.8) |
| (10.0 to 19.9%) | 1,080 | 327 (30.3) | 136 (12.6) | 136 (12.6) | 370 (34.3) |
| (20.0+%) | 629 | 271 (43.1) | 122 (19.4) | 98 (15.6) | 286 (45.5) |
IFG: impaired fasting glucose; HDLC: high-density-lipoprotein cholesterol; TG: triglyceride.
* : Differences in the proportions of each component were tested by χ2 test (all p<0.001).
Table 2. Odds ratios of having two or more metabolic syndrome components according to weight difference categories.
| Weight difference categories | n | Odds ratio (95% confidence interval) | |
| Crude | Multivariate-adjusted* | ||
| Loss (to −4.1%) | 278 | 0.82 (0.54-1.25) | 0.61 (0.39-0.94) |
| Stable (−4.0 to 3.9%) | 711 | 1 (reference) | 1 (reference) |
| Gain (4.0 to 9.9%) | 701 | 1.19 (0.89-1.59) | 1.28 (0.95-1.73) |
| (10.0 to 19.9%) | 1,080 | 2.07 (1.61-2.66) | 2.49 (1.91-3.24) |
| (20.0+%) | 629 | 3.72 (2.85-4.85) | 5.30 (3.97-7.07) |
* : Adjusted for age, height and weight at age 25, smoking status (never, past, current smoker of 1-24 and 25 or more cigarettes per day), drinking (none, light, moderate, and heavy), and physical activity (not very active, somewhat active, and regularly active).
Multivariate-adjusted fasting insulin concentration differed significantly in the quartiles of weight-RMSE and weight-slope (p=0.002 and 0.033, respectively) (Table 3).9 The greater the weight-RMSE or weight-slope was, the higher the insulin concentration became accordingly (p for trend <0.001 and =0.033, respectively).
Table 3. Serum insulin concentration according to weight-RMSE and weight-slope.
| Quartiles of weight-RMSE/weight-sloope | |||||||||||
| Q1 | Q2 | Q3 | Q4 | p* | trend p | ||||||
| n | mean (95%CI) | n | mean (95%CI) | n | mean (95%CI) | n | mean (95%CI) | ||||
| Weight-RMSE | Model 1† | 4.2 (4.0-4.4) | 4.3 (4.1-4.5) | 4.4 (4.1-4.6) | 5.0 (47-5.2)|| | <0.001 | <0.001 | ||||
| Model 2‡ | 474 | 4.2 (4.1-44) | 479 | 4.3 (4.1-4.5) | 459 | 4.5 (4.3-4.7) | 467 | 4.8 (4.6-5.0)¶ | 0.002 | <0.001 | |
| Model 3§ | 4.2 (4.1-4.4) | 4.3 (4.1-4.5) | 4.5 (4.3-4.7) | 4.8 (4.5-5.0)¶ | 0.002 | <0.001 | |||||
| Weight-slope | Model 1* | 3.1 (2.9-3.2) | 4.0 (3.8-4.2)** | 4.8 (4.5-5.0)¶ | 6.6 (6.3-6.9)|| | <0.001 | <0.001 | ||||
| Model 2† | 480 | 4.2 (3.9-4.6) | 452 | 4.3 (4.1-4.5) | 466 | 4.4 (4.2-4.6) | 481 | 4.9 (4.5-5.2)†† | 0.050 | 0.059 | |
| Model 3‡ | 4.2 (3.9-4.5) | 4.3 (4.1-4.5) | 4.4 (4.2-4.6) | 4.9 (46-5.2)‡‡ | 0.033 | 0.033 | |||||
CI: confidence interval; RMSE: root mean square error
* : P values by one-way analysis of variance in Model 1 and one-way analysis of covariance in Model 2 and 3.
† : Crude mean
‡ : Age, body mass index at baseline and at age 20, and weight change slope adjusted mean
§ : Age, body mass index at baseline and at age 20, weight change slope, awareness of stress, smoking status (never, past, current smoker of 1-24 and 25 or more cigarettes per day), drinking (none, light, moderate, and heavy), and physical activity (not very active, somewhat active, and regularly active) adjusted mean
|| : significantly higher than Q1, Q2, and Q3 by Sidak method
¶ : significantly higher than Q1 and Q2 by Sidak method
** : significantly higher than Q1 by Sidak method
†† : significantly higher than Q3 by Sidak method
‡‡ : significantly higher than Q2, and Q3 by Sidak method
A similar result was published in reference No. 9.
DISCUSSION
In the present analyses using longitudinal weight history data, an independent and dose-dependent association was found between weight difference since young adulthood and each metabolic syndrome component and their clustering. Second, weight gain or loss (weight-slope) and weight fluctuation (weight-RMSE) were both associated with insulin concentration. The amount of weight difference was significantly associated with insulin concentration as well (data not shown). Another study of ours had revealed that weight fluctuation was also associated with metabolic syndrome.10 These results indicated that risk factors would cluster on the basis of a physiologic background formed or characterized by adult weight gain and weight fluctuation. We have revealed in the present study that weight fluctuation was associated with high fasting insulin concentration independent of current weight and weight gain or loss. Taken together, fasting hyperinsulinemia was suggested to be a common physiologic background from weight gain or weight fluctuation to metabolic syndrome.
Although this is a cross-sectional study in which determination of the cause-effect relationship requires further investigation, several mechanisms by which weight fluctuation would lead to hyperinsulinemia can be considered. First, increased insulin concentration might reflect a change in adiposity. A significant increase in visceral fat mass as a long-term consequence of weight cycling was reported in an experimental study in rats.11 Adipose tissues were also found to be significantly enlarged in weight-cycled rats.12 Two studies in humans found a positive association of weight fluctuation with waist-hip ratio,13 or truncal adiposity.14 Further studies using the degree of total or abdominal adiposity are warranted.
Second, a thrifty phenotype,15 postulated as an adaptive metabolic dynamic state to a famine-and-feast lifestyle, and characterized as suppressed thermogensis with concomitant skeletal muscle insulin resistance, may explain the present finding of a high fasting insulin level in weight-fluctuating individuals. Co-existing adipose tissue insulin hyper-responsiveness serves to replenish its fat store rapidly when the food becomes available.15 The phenotype can be maladaptive in the modern lifestyle of an industrialized society characterized by low physical activity and readily available energy-dense diets so as to exacerbate suppression of thermogenesis and lead to excess adiposity in regaining weight.15
As mentioned earlier, the cross-sectional nature of the present study cannot exclude the possibility that the insulin concentration is the cause rather than the consequence of weight fluctuation. Indeed, there have been studies regarding whether or not baseline insulin levels precede weight change, but with inconsistent findings.16-18 Therefore, although the present study has indicated the association between weight fluctuation and higher insulin concentrations, determination of the cause-effect relationship requires further investigation.
The present study used weight fluctuation over a longer period than any other studies, and the measure was based on previously determined weight, as opposed to recalled weight. Associations of disease with weight using self-reported measures are known to result in underestimation because overweight individuals tend to underreport while the underweight tend to overreport.19 In addition, the large sample size provided the strong statistical power to detect intercategorical differences.
Weight fluctuation, per se, has been associated with the risk of increased cardiovascular diseases in some prospective studies even after adjustment for the degree of obesity.20,21 These associaions could be explained at least partly by the link between weight fluctuation and high insulin concentration, or with metabolic syndrome.10 We have also examined and found a significant and positive association of weight fluctuation with the level of C-reactive protein (CRP), a marker for underlying systemic inflammation,22 and speculated that CRP elevation may be another pathway from weight fluctuation to cardiovascular risk. CRP is an acute phase reactant,23 a marker for underlying systemic inflammation, and an elevated CRP level has been shown as a strong independent predictor of future cardiovascular diseases .24-26
Altered levels of adipocytokines, such as leptin or adiponectin secreted from excess adipose tissue as a consequence of adult weight gain or weight fluctuation,27 may be pathogenically involved in the risk factors' clustering or arteriosclerosis directly. Leptin concentration was found to be linearly associated with white blood cell counts,28 a possible marker for future cardiovascular mortality.29 Blood pressure level was also related to leptin concentration independent of insulin level,30 and decrease in adiponectin level was associated with metabolic syndrome.31 Adiponectin concentration was inversely associated with CRP level in extremely healthy individuals, suggesting its anti-inflammatory and anti-arteriosclerotic property.32 It might be causally associated with the development of left ventricular hypertrophy.33
One of the limitations of the present study may be related to the fact that participants were a series of employees who had been working in a company from around the age of 20, and had been able to keep working until the year 1997. There may have been a group of individuals with large weight fluctuation that had dropped out before the baseline. Thus, the present result may apply only to a relatively healthier population.
In conclusion, from these cross-sectional analyses of middle-aged Japanese men, we found a positive association between the fasting serum insulin concentration and weight fluctuation that occurred from young adulthood even after adjustment for the degree of obesity. The mechanisms for this remain to be solved, and investigations must be undertaken on possible alteration of insulin metabolisms in human by the level of weight fluctuation, and measurement of changes in adiposity are also needed.
ACKNOWLEDGMENTS
The author would like to express his sincere appreciation to Professor Hideaki Toyoshima and Associate Professor Koji Tamakoshi of the Department of Public Health who have been guiding this line of research. He is also grateful to the workers who participated in the Aichi worksite cohort study, and the staffs of the personnel healthcare division. The study has been carried out with the collaboration of the following researchers: Drs. Kondo T, Zhu SK, Hori Y, Suma M, Zhang HM, Wada K, and Otsuka-Ito R. The author would also like to acknowledge the Japan Epidemiological Association for the award and the Editorial board of the Journal of Epidemiology for providing him with this opportunity to report the contents of the study.
REFERENCES
- 1.Iso H, Sato S, Kitamura A, Imano H, Kiyama M, Yamagishi K, et al. Metabolic Syndrome and the Risk of Ischemic Heart Disease and Stroke Among Japanese Men and Women. Stroke 2007; 38: 1744-51. 10.1161/STROKEAHA.106.469072 [DOI] [PubMed] [Google Scholar]
- 2.Despres JP, Lemieux I. Abdominal obesity and metabolic syndrome. Nature 2006; 444: 881-7. 10.1038/nature05488 [DOI] [PubMed] [Google Scholar]
- 3.Haffner SM, Valdez RA, Hazuda HP, Mitchell BD, Morales PA, Stern MP. Prospective analysis of the insulin-resistance syndrome (syndrome X). Diabetes 1992; 41: 715-22. 10.2337/diab.41.6.715 [DOI] [PubMed] [Google Scholar]
- 4.Hannerz H, Albertsen K, Nielsen ML, Tuchsen F, Burr H. Occupational factors and 5-year weight change among men in a danish national cohort. Health Psychol 2004; 23: 283-8. 10.1037/0278-6133.23.3.283 [DOI] [PubMed] [Google Scholar]
- 5.Kivimaki M, Head J, Ferrie JE, Shipley MJ, Brunner E, Vahtera J, et al. Work stress, weight gain and weight loss: evidence for bidirectional effects of job strain on body mass index in the Whitehall II study. Int J Obes (Lond) 2006; 30: 982-7. 10.1038/sj.ijo.0803229 [DOI] [PubMed] [Google Scholar]
- 6.Yatsuya H, Tamakoshi K, Hattori H, Otsuka R, Wada K, Zhang H, et al. Serum phospholipid transfer protein mass as a possible protective factor for coronary heart diseases. Circ J 2004; 68: 11-6. 10.1253/circj.68.11 [DOI] [PubMed] [Google Scholar]
- 7.Yatsuya H, Ohwaki A, Tamakoshi K, Wakai K, Koide K, Otsuka R, et al. Reproducibility and validity of a simple checklist-type questionnaire for food intake and dietary behavior. J Epidemiol 2003; 13: 235-45. 10.2188/jea.13.235 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Otsuka R, Yatsuya H, Tamakoshi K, Matsushita K, Wada K, Toyoshima H.. Perceived psychological stress and serum leptin concentrations in Japanese men. Obesity (Silver Spring) 2006; 14: 1832-8. 10.1038/oby.2006.211 [DOI] [PubMed] [Google Scholar]
- 9.Yatsuya H, Tamakoshi K, Yoshida T, Hori Y, Zhang H, Ishikawa M, et al. Association between weight fluctuation and fasting insulin concentration in Japanese men. Int J Obes Relat Metab Disord 2003; 27: 478-83. 10.1038/sj.ijo.0802221 [DOI] [PubMed] [Google Scholar]
- 10.Zhang H, Tamakoshi K, Yatsuya H, Murata C, Wada K, Otsuka R, et al. Long-term body weight fluctuation is associated with metabolic syndrome independent of current body mass index among Japanese men. Circ J 2005; 69: 13-8. 10.1253/circj.69.13 [DOI] [PubMed] [Google Scholar]
- 11.Lu H, Buison A, Uhley V, Jen KL. Long-term weight cycling in female Wistar rats: effects on metabolism. Obes Res 1995; 3: 521-30. 10.1002/j.1550-8528.1995.tb00186.x [DOI] [PubMed] [Google Scholar]
- 12.Sea MM, Fong WP, Huang Y, Chen ZY. Weight cycling-induced alteration in fatty acid metabolism. Am J Physiol Regul Integr Comp Physiol 2000; 279: R1145-55. [DOI] [PubMed] [Google Scholar]
- 13.Rodin J, Radke-Sharpe N, Rebuffe-Scrive M, Greenwood MR. Weight cycling and fat distribution. Int J Obes 1990; 14: 303-10. [PubMed] [Google Scholar]
- 14.Lissner L, Andres R, Muller DC, Shimokata H. Body weight variability in men: metabolic rate, health and longevity. Int J Obes 1990; 14: 373-83. [PubMed] [Google Scholar]
- 15.Dulloo AG, Jacquet J, Seydoux J, Montani JP. The thrifty 'catch-up fat' phenotype: its impact on insulin sensitivity during growth trajectories to obesity and metabolic syndrome. Int J Obes (Lond) 2006; 30 Suppl 4: S23-35. 10.1038/sj.ijo.0803516 [DOI] [PubMed] [Google Scholar]
- 16.Wedick NM, Mayer-Davis EJ, Wingard DL, Addy CL, Barrett-Connor E. Insulin resistance precedes weight loss in adults without diabetes : the Rancho Bernardo Study. Am J Epidemiol 2001; 153: 1199-205. 10.1093/aje/153.12.1199 [DOI] [PubMed] [Google Scholar]
- 17.Gould AJ, Williams DE, Byrne CD, Hales CN, Wareham NJ. Prospective cohort study of the relationship of markers of insulin resistance and secretion with weight gain and changes in regional adiposity. Int J Obes Relat Metab Disord 1999; 23: 1256-61. 10.1038/sj.ijo.0801060 [DOI] [PubMed] [Google Scholar]
- 18.Zavaroni I, Zuccarelli A, Gasparini P, Massironi P, Barilli A, Reaven GM. Can weight gain in healthy, nonobese volunteers be predicted by differences in baseline plasma insulin concentration? J Clin Endocrinol Metab 1998; 83: 3498-500. [DOI] [PubMed] [Google Scholar]
- 19.Tamakoshi K, Yatsuya H, Kondo T, Hirano T, Hori Y, Yoshida T, et al. The accuracy of long-term recall of past body weight in Japanese adult men. Int J Obes Relat Metab Disord 2003; 27: 247-52. 10.1038/sj.ijo.802195 [DOI] [PubMed] [Google Scholar]
- 20.Iribarren C, Sharp DS, Burchfiel CM, Petrovitch H. Association of weight loss and weight fluctuation with mortality among Japanese American men. N Engl J Med 1995; 333: 686-92. 10.1056/NEJM199509143331102 [DOI] [PubMed] [Google Scholar]
- 21.Peters ET, Seidell JC, Menotti A, Arayanis C, Dontas A, Fidanza F, et al. Changes in body weight in relation to mortality in 6441 European middle-aged men: the Seven Countries Study. Int J Obes Relat Metab Disord 1995; 19: 862-8. [PubMed] [Google Scholar]
- 22.Tamakoshi K, Yatsuya H, Kondo T, Ishikawa M, Zhang H, Murata C, et al. Long-term body weight variability is associated with elevated C-reactive protein independent of current body mass index among Japanese men. Int J Obes Relat Metab Disord 2003; 27: 1059-65. 10.1038/sj.ijo.0802386 [DOI] [PubMed] [Google Scholar]
- 23.Pepys MB, Hirschfield GM. C-reactive protein: a critical update. J Clin Invest 2003; 111: 1805-12. 10.1172/JCI200318921 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Koenig W, Sund M, Frohlich M, Fischer HG, Lowel H, Doring A, et al. C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992. Circulation 1999; 99: 237-42. 10.1161/01.CIR.99.2.237 [DOI] [PubMed] [Google Scholar]
- 25.Ridker PM, Buring JE, Shih J, Matias M, Hennekens CH. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation 1998; 98: 731-3. 10.1161/01.CIR.98.8.731 [DOI] [PubMed] [Google Scholar]
- 26.Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997; 336: 973-9. 10.1056/NEJM199704033361401 [DOI] [PubMed] [Google Scholar]
- 27.Montani JP, Viecelli AK, Prevot A, Dulloo AG. Weight cycling during growth and beyond as a risk factor for later cardiovascular diseases: the 'repeated overshoot' theory. Int J Obes (Lond) 2006; 30 Suppl 4: S58-66. 10.1038/sj.ijo.0803520 [DOI] [PubMed] [Google Scholar]
- 28.Mabuchi T, Yatsuya H, Tamakoshi K, Otsuka R, Nagasawa N, Zhang H, et al. Association between serum leptin concentration and white blood cell count in middle-aged Japanese men and women. Diabetes Metab Res Rev 2005; 21: 441-7. 10.1002/dmrr.540 [DOI] [PubMed] [Google Scholar]
- 29.Tamakoshi K, Toyoshima H, Yatsuya H, Matsushita K, Okamura T, Hayakawa T, et al. White blood cell count and risk of all-cause and cardiovascular mortality in nationwide sample of Japanese — results from the NIPPON DATA90. Circ J 2007; 71: 479-85. 10.1253/circj.71.479 [DOI] [PubMed] [Google Scholar]
- 30.Wada K, Yatsuya H, Tamakoshi K, Otsukai R, Fujii C, Matsushita K, et al. A positive association between leptin and blood pressure of normal range in Japanese men. Hypertens Res 2006; 29: 485-92. 10.1291/hypres.29.485 [DOI] [PubMed] [Google Scholar]
- 31.Matsushita K, Yatsuya H, Tamakoshi K, Wada K, Otsuka R, Takefuji S, et al. Comparison of circulating adiponectin and proinflammatory markers regarding their association with metabolic syndrome in Japanese men. Arterioscler Thromb Vasc Biol 2006; 26: 871-6. 10.1161/01.ATV.0000208363.85388.8f [DOI] [PubMed] [Google Scholar]
- 32.Matsushita K, Yatsuya H, Tamakoshi K, Wada K, Otsuka R, Zhang H, et al. Inverse association between adiponectin and C-reactive protein in substantially healthy Japanese men. Atherosclerosis 2006; 188: 184-9. 10.1016/j.atherosclerosis.2005.10.031 [DOI] [PubMed] [Google Scholar]
- 33.Mitsuhashi H, Yatsuya H, Tamakoshi K, Matsushita K, Otsuka R, Wada K, et al. Adiponectin Level and Left Ventricular Hypertrophy in Japanese Men. Hypertension 2007; 49: 1448-54. 10.1161/HYPERTENSIONAHA.106.079509 [DOI] [PubMed] [Google Scholar]